Target intelligence / Profile preview

Neuronal migration protein doublecortin (DCX)

Target
DCX
Molecular classification
Microtubule-associated protein (MAP), Other
01

Overview

Neuronal migration protein doublecortin (DCX) is a microtubule-associated protein that plays a critical role in the migration of immature neurons during developmental neurogenesis, particularly in the cortex[1][2][3][4][5]. DCX binds and stabilizes microtubules, promotes their polymerization, and is essential for correct layering of neurons in the developing brain[1][3][5]. It interacts through two tandemly repeated DC (doublecortin) domains that enable cooperative binding to the microtubule lattice, directly influencing microtubule architecture, rigidity, and dynamics[1][2][5]. Mutations in the DCX gene cause X-linked lissencephaly and subcortical band heterotopia—disorders resulting in abnormal neuronal migration, intellectual disabilities, and epilepsy[2][4][5]. DCX is predominantly expressed in neuronal precursor cells and immature neurons and is widely used as a research marker for neurogenesis, but it is not currently a direct therapeutic target. Experimental evidence indicates that DCX also influences microtubule posttranslational modification, including α-tubulin polyglutamylation, impacting neuronal branching in development[2]. Disruptions to DCX function are associated with defects in microtubule regulation, impaired migration, and structural brain abnormalities.

Other names
doublinlissencephalin-Xdoublecortexdoublecortin-X
02

Mechanism of action

Microtubule stabilization; Promotion of microtubule polymerization; Regulation of tubulin post-translational modification (polyglutamylation)

03

Biological functions

Neuronal migrationMicrotubule stabilizationMicrotubule polymerizationRegulation of neurite branchingNeurogenesis
04

Disease associations

Neurodevelopmental diseaseEpilepsyLissencephalySubcortical band heterotopia ("double cortex" syndrome)
05

Safety considerations

Mutations cause severe neurodevelopmental disorders (lissencephaly, subcortical band heterotopia)Not a typical therapeutic target—manipulation may affect normal brain development and neurogenesis[2][3][5]
06

Interacting drugs

Paclitaxel (positive effect shown in cellular models)[2]
07

Biomarkers

Marker of neurogenesis (DCX immunoreactivity used in research for neurogenic activity)Antibodies such as Abcam 18732

Beyond the preview

Go deeper on Neuronal migration protein doublecortin (DCX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal migration protein doublecortin (DCX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call